Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
453 studies found for:    Open Studies | "Hormones"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hormones"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer
Conditions: Hormone Dependent Neoplasms;   Breast Cancer Female
Intervention: Drug: Aromatase Inhibitors
2 Not yet recruiting Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment
Condition: Growth Hormone Treatment
Intervention: Behavioral: Play Back Sessions
3 Recruiting A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somavaratan
4 Recruiting A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Condition: Metastatic Hormone Sensitive Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo
5 Recruiting Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: PEG-somatropin
6 Recruiting Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Biological: Jintropin AQ
7 Recruiting Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
8 Recruiting A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Interventions: Drug: somapacitan;   Drug: Norditropin
9 Recruiting Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: Norditropin® FlexPro® pen
10 Not yet recruiting A Phase 1, First-in-Human, Multi-Part Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Intervention: Drug: RAD140
11 Recruiting Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients
Conditions: Burns;   Growth Hormone Treatment
Interventions: Drug: Somatropin;   Drug: 0.09% Saline Solution
12 Recruiting Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
Conditions: Ductal Infiltrating Metastatic Breast Cancer;   Hormone-receptors Positive Breast Cancer
Intervention: Biological: Circulating tumor cells counting at baseline
13 Recruiting Impact of Recombinant Human Growth Hormone on HIV Persistence
Conditions: Human Immunodeficiency Virus;   Growth Hormone Treatment
Intervention: Drug: Somatotropin (Human)
14 Recruiting Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Conditions: Early-Stage Breast Carcinoma;   Hormone Receptor Positive Tumor
Interventions: Drug: Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin;   Drug: Palbociclib
15 Recruiting Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)
Conditions: Pediatric Growth Hormone Deficiency;   Growth Disorders
Intervention: Drug: Somavaratan (VRS-317)
16 Recruiting Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
Condition: Growth Hormone Deficiency
Intervention: Biological: PEG-somatropin
17 Not yet recruiting Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy
Conditions: IGHD - Isolated Growth Hormone Deficiency;   Growth Retardation
Interventions: Dietary Supplement: Nutritional supplementation standardized formula;   Dietary Supplement: Placebo
18 Recruiting Versartis Long-Term Safety Study of Somavaratan
Condition: Pediatric Growth Hormone Deficiency
Intervention: Drug: somavaratan
19 Recruiting Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
Condition: Adult Growth Hormone Deficiency (AGHD)
Intervention: Drug: somavaratan
20 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.